FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055361378> ?p ?o ?g. }

• W2055361378 endingPage "212" @default.
• W2055361378 startingPage "208" @default.
• W2055361378 abstract "In Brief Objective: The objective of our study was to show the impact of different chemotherapy regimens on the incidence of amenorrhea (chemotherapy-induced amenorrhea [CIA]) in premenopausal women of various ages with breast cancer. Methods: This is a follow-up study of 226 premenopausal women with breast cancer who had received one of three chemotherapy regimens: conventional (cyclophosphamide/methotrexate/5-fluorouracil), anthracycline based, and anthracycline-taxane based. They were evaluated for the incidence of CIA in the follow-up clinic of the Iranian Center for Breast Cancer. A statistical analysis using SPSS software was performed, and logistic regression and Cox regression model were used to determine the risk factors for CIA. Results: Of the 226 women with a median age of 40 years (range, 26-56 y) who participated in this study, 154 (68.1%) developed CIA. In 101 (65.6%) of these women, CIA was established. CIA was present in 52.5% of the women who had been treated with conventional regimens (cyclophosphamide/methotrexate/5-fluorouracil), 66.7% of the women who had been treated with anthracycline, and 78.7% of the women who had been treated with anthracycline-taxane. Therefore, the frequency of CIA was significantly higher in the taxane-based chemotherapy group than in the other groups (P = 0.015). Although a slightly higher incidence of CIA in women with hormone-insensitive tumors (estrogen receptor negative and progesterone receptor negative) versus hormone-sensitive tumors (estrogen receptor positive and progesterone receptor positive) who had been treated with combination regimens was observed, no statistically significant difference was found (P = 0.629). Of all of the risk factors that were evaluated in the study, anthracycline-taxane-based regimens (odds ratio, 4.059; 95% CI, 1.6-9.8) and age older than 40 years (odds ratio, 3.5; 95% CI, 1.9-6.6) were the most important factors in the development of CIA. Conclusions: The type of chemotherapy and the age of the woman at the onset of breast cancer are the most important risk factors in CIA. Taxane-based regimens induced more CIA than did other regimens. According to this study, taxane-based chemotherapy regimens and age at diagnosis of more than 40 years are the most important risk factors in chemotherapy-induced amenorrhea in patients with breast cancer." @default.
• W2055361378 created "2016-06-24" @default.
• W2055361378 creator A5019594728 @default.
• W2055361378 creator A5023237323 @default.
• W2055361378 creator A5040703994 @default.
• W2055361378 creator A5047066925 @default.
• W2055361378 creator A5065144831 @default.
• W2055361378 creator A5065626218 @default.
• W2055361378 creator A5079404893 @default.
• W2055361378 creator A5081651440 @default.
• W2055361378 creator A5091414143 @default.
• W2055361378 date "2011-02-01" @default.
• W2055361378 modified "2023-09-26" @default.
• W2055361378 title "Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea" @default.
• W2055361378 cites W120963284 @default.
• W2055361378 cites W1964979154 @default.
• W2055361378 cites W1972595386 @default.
• W2055361378 cites W1980544879 @default.
• W2055361378 cites W1982148917 @default.
• W2055361378 cites W2001101808 @default.
• W2055361378 cites W2008308937 @default.
• W2055361378 cites W2017861483 @default.
• W2055361378 cites W2038652818 @default.
• W2055361378 cites W2065704671 @default.
• W2055361378 cites W2075557130 @default.
• W2055361378 cites W2088996917 @default.
• W2055361378 cites W2092250810 @default.
• W2055361378 cites W2111006367 @default.
• W2055361378 cites W2117151785 @default.
• W2055361378 cites W2155902341 @default.
• W2055361378 cites W2159102253 @default.
• W2055361378 doi "https://doi.org/10.1097/gme.0b013e3181f3e6e7" @default.
• W2055361378 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21037487" @default.
• W2055361378 hasPublicationYear "2011" @default.
• W2055361378 type Work @default.
• W2055361378 sameAs 2055361378 @default.
• W2055361378 citedByCount "21" @default.
• W2055361378 countsByYear W20553613782012 @default.
• W2055361378 countsByYear W20553613782013 @default.
• W2055361378 countsByYear W20553613782014 @default.
• W2055361378 countsByYear W20553613782015 @default.
• W2055361378 countsByYear W20553613782016 @default.
• W2055361378 countsByYear W20553613782017 @default.
• W2055361378 countsByYear W20553613782019 @default.
• W2055361378 countsByYear W20553613782021 @default.
• W2055361378 countsByYear W20553613782022 @default.
• W2055361378 countsByYear W20553613782023 @default.
• W2055361378 crossrefType "journal-article" @default.
• W2055361378 hasAuthorship W2055361378A5019594728 @default.
• W2055361378 hasAuthorship W2055361378A5023237323 @default.
• W2055361378 hasAuthorship W2055361378A5040703994 @default.
• W2055361378 hasAuthorship W2055361378A5047066925 @default.
• W2055361378 hasAuthorship W2055361378A5065144831 @default.
• W2055361378 hasAuthorship W2055361378A5065626218 @default.
• W2055361378 hasAuthorship W2055361378A5079404893 @default.
• W2055361378 hasAuthorship W2055361378A5081651440 @default.
• W2055361378 hasAuthorship W2055361378A5091414143 @default.
• W2055361378 hasConcept C120665830 @default.
• W2055361378 hasConcept C121332964 @default.
• W2055361378 hasConcept C121608353 @default.
• W2055361378 hasConcept C126322002 @default.
• W2055361378 hasConcept C143998085 @default.
• W2055361378 hasConcept C2776694085 @default.
• W2055361378 hasConcept C2776755627 @default.
• W2055361378 hasConcept C2776802502 @default.
• W2055361378 hasConcept C2777511904 @default.
• W2055361378 hasConcept C2778058571 @default.
• W2055361378 hasConcept C2779234561 @default.
• W2055361378 hasConcept C29456083 @default.
• W2055361378 hasConcept C530470458 @default.
• W2055361378 hasConcept C54355233 @default.
• W2055361378 hasConcept C61511704 @default.
• W2055361378 hasConcept C71924100 @default.
• W2055361378 hasConcept C84606932 @default.
• W2055361378 hasConcept C86803240 @default.
• W2055361378 hasConceptScore W2055361378C120665830 @default.
• W2055361378 hasConceptScore W2055361378C121332964 @default.
• W2055361378 hasConceptScore W2055361378C121608353 @default.
• W2055361378 hasConceptScore W2055361378C126322002 @default.
• W2055361378 hasConceptScore W2055361378C143998085 @default.
• W2055361378 hasConceptScore W2055361378C2776694085 @default.
• W2055361378 hasConceptScore W2055361378C2776755627 @default.
• W2055361378 hasConceptScore W2055361378C2776802502 @default.
• W2055361378 hasConceptScore W2055361378C2777511904 @default.
• W2055361378 hasConceptScore W2055361378C2778058571 @default.
• W2055361378 hasConceptScore W2055361378C2779234561 @default.
• W2055361378 hasConceptScore W2055361378C29456083 @default.
• W2055361378 hasConceptScore W2055361378C530470458 @default.
• W2055361378 hasConceptScore W2055361378C54355233 @default.
• W2055361378 hasConceptScore W2055361378C61511704 @default.
• W2055361378 hasConceptScore W2055361378C71924100 @default.
• W2055361378 hasConceptScore W2055361378C84606932 @default.
• W2055361378 hasConceptScore W2055361378C86803240 @default.
• W2055361378 hasIssue "2" @default.
• W2055361378 hasLocation W20553613781 @default.
• W2055361378 hasLocation W20553613782 @default.
• W2055361378 hasOpenAccess W2055361378 @default.
• W2055361378 hasPrimaryLocation W20553613781 @default.

• next